AQTrofymenko O, Bordeaux JS, Zeitouni NC. Survival in patients with primary dermatofibrosarcoma protuberans: national cancer database analysis. J Am Acad Dermatol. 2018;78:1125–34.
Mujtaba B, Wang F, Taher A, Aslam R, Madewell JE, Spear R, Nassar S. Dermatofibrosarcoma protuberans: pathological and imaging review. Curr Probl Diagn Radiol. 2021;50:236–40.
Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol. 2007;56:968–73.
Zhang L, Liu Q, Cao Y, Zhong J, Zhang W. Dermatofibrosarcoma protuberans: computed tomography and magnetic resonance imaging findings. Med (Baltim). 2015;94:e1001.
Kreicher KL, Kurlander DE, Gittleman HR, Barnholtz-Sloan JS, Bordeaux JS. Incidence and survival of primary dermatofibrosarcoma protuberans in the United States. Dermatol Surg. 2016;42:S24-31.
Article CAS PubMed Google Scholar
Hao X, Billings SD, Wu F, Stultz TW, Procop GW, Mirkin G, Vidimos AT. Dermatofibrosarcoma protuberans: update on the diagnosis and treatment. J Clin Med. 2020;9:1752.
Article CAS PubMed PubMed Central Google Scholar
Allen A, Ahn C, Sangüeza OP. Dermatofibrosarcoma protuberans. Dermatol Clin. 2019;37:483–8.
Article CAS PubMed Google Scholar
Saiag P, Grob J-J, Lebbe C, Malvehy J, Del Marmol V, Pehamberger H, Peris K, Stratigos A, Middelton M, Basholt L. Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51:2604–8.
Martin ECS, Vyas KS, Batbold S, Erwin PJ, Brewer JD. Dermatofibrosarcoma protuberans recurrence after wide local excision versus Mohs micrographic surgery: a systematic review and meta-analysis. Dermatol Surg. 2022;48(5):479–85.
Article CAS PubMed Google Scholar
Chen Y, Jiang G. Association between surgical excision margins and outcomes in patients with dermatofibrosarcoma protuberans: a meta-analysis. Dermatol Ther. 2021;34: e14954.
Rutkowski P, Klimczak A, Ługowska I, Jagielska B, Wągrodzki M, Dębiec-Rychter M, Pieńkowska-Grela B, Świtaj T. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate–the impact of fibrosarcomatous transformation. European Journal of Surgical Oncology (EJSO). 2017;43:1134–41.
Article CAS PubMed Google Scholar
Zwald FO. Underuse of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: comment on efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Arch Dermatol. 2012;148:1064–1064.
Liang CA, Jambusaria-Pahlajani A, Karia PS, Elenitsas R, Zhang PD, Schmults CD. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change. J Am Acad Dermatol. 2014;71:781–6.
Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD. Fibrosarcomatous (high-grade) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol. 1998;22:576–87.
Article CAS PubMed Google Scholar
Du K, Li J, Tang L, Lin X, Kong X, Liao X, Peng Q, Dong Y, He J, Huang Y. Role of postoperative radiotherapy in dermatofibrosarcoma protuberans: a propensity score-matched analysis. Radiat Oncol. 2019;14:1–8.
Jing C, Zhang H, Zhang X, Yu S. Dermatofibrosarcoma protuberans: a clinicopathologic and therapeutic analysis of 254 cases at a single institution. Dermatol Surg. 2021;47:e26–30.
Article CAS PubMed Google Scholar
Angouridakis N, Kafas P, Jerjes W, Triaridis S, Upile T, Karkavelas G, Nikolaou A. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck. Head Neck Oncol. 2011;3:1–7.
Jozwik M, Bednarczuk K, Osierda Z. Dermatofibrosarcoma protuberans: an updated review of the literature. Cancers. 2024;16:3124.
Article CAS PubMed PubMed Central Google Scholar
Hu M-Y, Kuo S-H. (2019) Adjuvant radiotherapy for dermatofibrosarcoma protuberans.
Rutkowski P, Andrzejuk J, Bylina E, Osuch C, Świtaj T, Jerzak vel Dobosz A, Grzesiakowska U, Jurkowska M, Woźniak A, Limon J. What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib? Med Oncol. 2013;30:1–11.
Navarrete-Dechent C, Mori S, Barker CA, Dickson MA, Nehal KS. Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: a systematic review. JAMA Dermatol. 2019;155:361–9.
Article PubMed PubMed Central Google Scholar
Criscito MC, Martires KJ, Stein JA. Prognostic factors, treatment, and survival in dermatofibrosarcoma protuberans. JAMA Dermatol. 2016;152:1365–71.
Wang C, Luo Z, Chen J, Zheng B, Zhang R, Chen Y, Shi Y. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with Imatinib mesylate: an analysis on 22 Chinese patients. Med (Baltim). 2015;94:e773.
Paramasivam S, Rastogi S. 86P Advanced dermatofibrosarcoma protuberans (DFSP): experience from a sarcoma clinic in India with 38 patients. ESMO Open. 2024;9(Suppl 2):102475. https://doi.org/10.1016/j.esmoop.2024.102475.
Shao K, Feng H. Racial and ethnic healthcare disparities in skin cancer in the United States: a review of existing inequities, contributing factors, and potential solutions. J Clin Aesthetic Dermatol. 2022;15:16.
Chen Y, Zhong N-N, Cao L-M, Liu B, Bu L-L. Surgical margins in head and neck squamous cell carcinoma: a narrative review. Int J Surg. 2024;110:3680–700.
Article PubMed PubMed Central Google Scholar
Chen S, Xiong L, Zhao L, Li Y, Li L. Survival outcomes and prognostic factors of dermatofibrosarcoma protuberans: a population-based retrospective cohort analysis. Dermatol Surg. 2023;49(9):825–831. https://doi.org/10.1097/DSS.0000000000003853.
Xiong J-X, Cai T, Hu L, Chen X-L, Huang K, Chen A-J, Wang P. Risk factors related to postoperative recurrence of dermatofibrosarcoma protuberans: a retrospective study and literature review. World J Clin Cases. 2021;9:5442.
Article PubMed PubMed Central Google Scholar
van Huis F, Grünhagen DJ, Smith MJ, van Akkooi AC, Wouters MW, Hayes AJ, Verhoef C, Strauss DC, van Houdt WJ. (2019) Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated? Cancer 125:735–741.
González A, Etchichury D, Rivero JM, Adamo L. Treatment of dermatofibrosarcoma of the head and neck with Mohs surgery with paraffin sections. J Plast Reconstr Aesthet Surg. 2021;74:1061–70.
Koseła H, Rutkowski P. Dermatofibrosarcoma protuberans (DFSP)–postępy w diagnostyce i Leczeniu. OncoReview. 2011;1:104–11.
Hayakawa K, Matsumoto S, Ae K, Tanizawa T, Gokita T, Funauchi Y, Motoi N. Risk factors for distant metastasis of dermatofibrosarcoma protuberans. J Orthop Traumatol. 2016;17:261–6.
Article PubMed PubMed Central Google Scholar
Chen H, Liu Y, Peng F, et al. Pulmonary metastases of fibrosarcomatous dermatofibrosarcoma protuberans respond to apatinib-based angiogenesis and chemotherapy: a case report. Ann Transl Med. 2019;7(7):149. https://doi.org/10.21037/atm.2019.02.20.
Article PubMed PubMed Central Google Scholar
Buck IIDW, Kim JY, Alam M, Rawlani V, Johnson S, Connor CM, Dumanian GA, Wayne JD. Multidisciplinary approach to the management of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 2012;67:861–6.
Edelweiss M, Malpica A. Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases. Am J Surg Pathol. 2010;34:393–400.
Muto Y, Fujimura T, Takahashi A, Namikawa K, Ogata D, Nakano E, Jinnai S, Hashimoto A, Kambayashi Y, Asano Y. Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: a multicenter study of 116 Japanese patients. J Dermatol. 2024(9). https://doi.org/10.1111/1346-8138.17280.
Gassenmaier M, Weber E, Leiter U, Hahn M, Forchhammer S, Häfner H-M, Scheu A, Garbe C, Schnabl SM. Micrographic surgery allows fascia preservation in dermatofibrosarcoma protuberans. Acta Derm Venereol. 2021;101(9):adv00561. https://doi.org/10.2340/00015555-3915.
Mani S, Kumar R, Kakkar A, Barwad A, Dheeraj K, Sagar P, Kumar R. Recurrent dermatofibrosarcoma protuberans of the head and neck: a case series. Indian J Surg Oncol. 2023;14:128–36.
Comments (0)